Synonyms:cinnarizine, 298-57-7, Stugeron, Stutgin, Cinarizine, Dimitronal, Stutgeron, Dimitron, Folcodal, Labyrin, Midronal, Mitronal, Glanil, Sepan, Cinazyn, Aplactan, Cinnageron, Lazeta, Marisan, Toliman, Cinaperazine, Cinnipirine, Cerepar, Cinnarizinum, Cerebolan, Cinarizina, Cinnacet, Corathiem, Giganten, Hilactan, Katoseran, Processine, Sedatromin, Siptazin, Spaderizine, Aplexal, Artate, Carecin, Denapol, Ixertol, Olamin, Eglen, 16699-20-0, 1-Benzhydryl-4-cinnamylpiperazine, R 516, 1-Cinnamyl-4-(diphenylmethyl)piperazine, R 1575, 516 MD, Piperazine, 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-, 1-Benzhydryl-4-cinnamylpiperazin, 1-benzhydryl-4-[(E)-3-phenylprop-2-enyl]piperazine, Stunarone, 1-(diphenylmethyl)-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine, (E)-1-Benzhydryl-4-cinnamylpiperazine, 1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine, R-516, 1-trans-Cinnamyl-4-diphenylmethylpiperazine, 1-benzhydryl-4-[(E)-cinnamyl]piperazine, CHEMBL43064, MLS000028498, 3DI2E1X18L, Piperazine, 1-cinnamyl-4-(diphenylmethyl)-, CHEBI:31403, R-1575, 516-MD, NSC-758400, 1-(Diphenylmethyl)-4-(3-phenyl-2-propen-1-yl)piperazine, Libotasin, Senoger, SMR000058307, Votegol, Zepamol, Cero-Aterin, Cinarizina [INN-Spanish], Cinnarizinum [INN-Latin], DTXCID802821, 1-(diphenylmethyl)-4-(3-phenylprop-2-en-1-yl)piperazine, Apotomin, Stonoron, Cinnarizine [USAN:INN:BAN:JAN], SR-01000003093, EINECS 206-064-8, MD 516, DTXSID3022821, BRN 0626121, UNII-3DI2E1X18L, Cinnarizine (JAN/USAN/INN), 1-Cinnamyl-4-diphenylmethylpiperazine, N-Benzhydryl-N'-cinnamylpiperazine, NCGC00015246-02, 1185242-27-6, CAS-298-57-7, Cinnarizine, powder, Prestwick_115, MFCD00056037, Piperazine, (E)-, CINNARIZINE [MI], Opera_ID_1776, Prestwick2_000278, Prestwick3_000278, CINNARIZINE [INN], CINNARIZINE [JAN], 1-(diphenylmethyl)-4-(3-phenylprop-2-enyl)piperazine, CINNARIZINE [USAN], C 5270, CINNARIZINE [MART.], Lopac0_000314, SCHEMBL44957, SCHEMBL44958, BSPBio_000156, CINNARIZINE [WHO-DD], MLS001148649, MLS002207295, MLS002222167, BPBio1_000172, GTPL9072, 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-piperazine, cid_1547484, CINNARIZINE [EP IMPURITY], DTXSID80859311, CHEBI:131176, 4-((2E)-3-phenylprop-2-enyl)-1-(diphenylmethyl)piperazine, CINNARIZINE [EP MONOGRAPH], HMS1568H18, HMS2095H18, HMS2234B20, HMS3260P10, HMS3712H18, HMS3885F20, component of Emesazine (Salt/Mix), HY-B1090, Tox21_110109, Tox21_500314, BDBM50017657, NSC290687, NSC771642, STK216257, AKOS002134299, Stugeron|Dimitronal|Stutgin|Cinarizine, Tox21_110109_1, CCG-204409, CS-4656, KS-5155, LP00314, NSC 758400, NSC-290687, NSC-771642, SDCCGSBI-0050302.P002, QTL1_000023, NCGC00018187-03, NCGC00018187-04, NCGC00018187-05, NCGC00018187-06, NCGC00018187-07, NCGC00018187-09, NCGC00018187-14, NCGC00021488-03, NCGC00021488-04, NCGC00021488-05, NCGC00260999-01, BC167081, LS-15144, EU-0100314, S4727, A16455, D01295, D89561, A820077, EN300-18169892, L001227, Q775073, 1-Benzhydryl-4-[3-phenyl-2-propenyl]piperazine #, SR-01000003093-2, SR-01000003093-6, W-106970, W-110442, 1-benzhydryl-4-[(2E)-3-phenylprop-2-enyl]piperazine, BRD-K07220430-001-03-6, BRD-K74927006-001-01-2, 1-[di(phenyl)methyl]-4-(3-phenylprop-2-enyl)piperazine, Cinnarizine, European Pharmacopoeia (EP) Reference Standard, PIPERAZINE, 1-(DIPHENYLMETHYL)-4-(3-PHENYL-2-PROPEN-1-YL)-, N90
Pubchem:PUBCHEM:1547484
Id:d94022a9-ba9d-55af-bb25-cc9ed929c3cd
Description:nan
